TITLE

Formulation and Evaluation of Valproic Acid Suppositories for Children

AUTHOR(S)
Alexandrina, Tăurean; Adriana, Ciurba; Nicoleta, Todoran; Cazacincu, R.; Maria, Dogaru T.
PUB. DATE
October 2011
SOURCE
Acta Medica Marisiensis;Oct2011, Vol. 57 Issue 5, p527
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Rectal suppositories of valproic acid were prepared using different lipophilic excipients: Suppocire NAI, Adeps solidus 50, Adeps solidus 3, Lipex 403, Cacao oleum. Each prepared suppository has been evaluated for various physical parameters like weight variation, disintegration and softening time and crushing (breaking) strength. Methods: Suppositories were prepared by fusion method. The quantity of active drug (valproic acid) added to the suppositories was 200 mg, thus resulting 1.0 g suppositories. Prepared suppositories were visually inspected. Randomly selected suppositories were cut longitudinally and the surfaces were examined with naked eye. For determination of weight variation, 20 suppositories were weighed and the average weight was determined. Disintegration time, softening time and breaking strength of the prepared suppositories were determined according to the 5th European Pharmacopoeia. Results: All the suppositories were free from pits, fissures and cracks. All formulas studied were disintegrated in less than 30 minutes. Valproic acid decreased the disintegration time of suppositories. The used excipient also influences the disintegration time, with a greater effect on the F1 formula (Suppocire NAI). After one month of preservation, the disintegration time of all formulas increased, but was less than 30 minutes. The softening time of the suppositories was the largest for the F1 formula (Suppocire NAI). The softening time decreases in the presence of valproic acid. The softening time and breaking strength increased for all formulas after one month. Conclusions: The prepared suppositories were within the permissible range of physical parameters. The results obtained allow the selection of excipients in order to assure the optimum characteristics for prepared suppositories.
ACCESSION #
69710246

Tags: SUPPOSITORIES;  VALPROIC acid;  DRUG lipophilicity;  DOSAGE forms of drugs;  EXCIPIENTS;  STABILIZING agents;  THERAPEUTICS;  EUROPEAN Pharmacopoeia (Book)

 

Related Articles

  • Rebranding Lipophilic Excipients. Ali, Shaukat; Karpynec, Nina // Pharmaceutical Technology;Sep2012, Vol. 36 Issue 9, p8 

    The article focuses on rebranding lipophilic excipients. The basis for rebranding with the same prefix is to identify molecules by structures, functions and the applications of choice; enable the company's brand products to be recognized; and to differentiate pharmaceutical excipients from other...

  • Rheological Behavior of Sodium Valproate Suppositories. Alexandrina, Tăurean; Adriana, Ciurba; Nicoleta, Todoran; Doina, Bumb; R., Cazacincu // Acta Medica Marisiensis;Apr2011, Vol. 57 Issue 2, p125 

    Background: Because the valproic derivates are frequently used in the treatment of epilepsy, bipolar disorders, major depression cases, migraines and other neurological disorders at children, the rectal administration is a real advantage.Aim: In this study we aimed to assess the influence of the...

  • Rebranding Lipophilic Excipients. Ali, Shaukat; Karpynec, Nina // Pharmaceutical Technology Europe;Sep2012, Vol. 24 Issue 9, p8 

    The article focuses on the rebranding of lipophilic excipeints. It says that the pharmaceutical industry relies on excipient manufacturers to design and produce excipients suitable to the dosage form and active pharmaceutical ingredients (API). It states that several excipient manufacturers are...

  • Epilim.  // Royal Society of Medicine: Medicines;2002, p230 

    The article presents information on Epilim, a proprietary, prescription-only preparation of the anticonvulsant and anti-epileptic sodium valproate. It can be used to treat all forms of epilepsy, and is available as tablets, a liquid and a syrup.

  • Manufacturing techniques and excipients used during the formulation of oil-in-water type nanosized emulsions for medical applications. Tamilvanan, Shunmugaperumal; Senthilkumar, Sudalaimuthu Ramachandran; baskar, Raj; Sekharan, Thenrajan Raja // Journal of Excipients & Food Chemicals;2010, Vol. 1 Issue 1, p11 

    Medically, the oil-in-water nanosized emulsions are used mainly as delivery carriers for lipophilic drug molecules which show therapeutic activity when administered via parenteral, ocular and transdermal routes. To extract multifunctional activities, the nanosized emulsions containing neutral,...

  • Biopharmaceutical Classification System :An Account. Yasir, Mohd; Asif, Mohd; Kumar, Ashwani; Aggarval, Abhinav // International Journal of PharmTech Research;Jul-Sep2010, Vol. 2 Issue 3, p1681 

    In 1995, Amidon and coworkers introduced the biopharmaceutical classification system (BCS) to reduce the need for in vivo bioequivalency studies, utilization of in vitro dissolution tests as a surrogate for in vivo bioequivalence studies. The principles of the BCS classification system can be...

  • suppository. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p722 

    An encyclopedia entry for "suppository" is presented. It refers to a solid medical preparation designed to be placed in the rectum to dissolve. They are used to treat rectal disorders such as proctitis or haemorrhoids, or to soften faeces and stimulate defaecation. Suppositories may either have...

  • Care Glycerin Suppositories for Adults.  // Royal Society of Medicine: Medicines;2002, p141 

    This article presents information on the drug Care Glycerin Suppositories for Adults. This drug is a proprietary, non-prescription preparation of the laxative glycerol. It can be used for the relief of constipation. Available as a suppository, it is not normally given to children, except on...

  • mesalazine.  // Royal Society of Medicine: Medicines;2002, p355 

    The article presents information on the aminosalicylate mesalazine. This drug can be used in the treatment of ulcerative colitis, particularly in patients sensitive to the sulphonamide content of sulfasalazine. Administration can be either oral or by suppositories or a foam enema.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics